Long‑Acting Reversible Contraception (LARC): IUDs, Implants & Injectables Compared

Long‑Acting Reversible Contraceptives (LARCs)—IUDs, implants, and injectables—are “forgettable” methods with effectiveness rivaling sterilization. They’re recommended as first‑line options for most people by ACOG, CDC, and WHO.

LARC Methods at a Glance

Method Type Duration Mechanism Typical‑Use Failure Key Features
Hormonal IUD (Mirena, Liletta, Kyleena, Skyla) LNG‑IUS 3–8 years Local progestin thickens cervical mucus, thins endometrium, reduces sperm motility 0.1–0.4% Lighter periods/amenorrhea; reduces dysmenorrhea; treats heavy menstrual bleeding
Copper IUD (Paragard) Cu‑IUD 10–12 years Copper ions toxic to sperm/ova; sterile inflammatory reaction 0.8% Non‑hormonal; heavier periods/cramps; can be used as emergency contraception (≤5 days)
Implant (Nexplanon) ENG rod 3–5 years Etonogestrel inhibits ovulation, thickens mucus 0.05% Most effective reversible method; irregular bleeding common
DMPA Injection (Depo‑Provera, Depo‑SubQ) DMPA 13 weeks Suppresses ovulation, thickens mucus, thins endometrium 4–6% No estrogen; amenorrhea common; reversible bone density loss; possible weight gain
Monthly Injection (Combined) E2 + NETE 4 weeks Suppresses ovulation 3–5% Monthly visit required; estrogen‑related risks

Hormonal IUD Details

Brand LNG Dose Duration Size Best For
Mirena 52 mg 8 years 32 mm Heavy menstrual bleeding (FDA‑approved); contraception
Liletta 52 mg 8 years 32 mm Cost‑effective; same hormone dose as Mirena
Kyleena 19.5 mg 5 years 28 mm Nulliparous; lower hormone dose
Skyla 13.5 mg 3 years 28 mm Nulliparous; lowest hormone; shorter duration

Key Advantages of LARC

  • Effectiveness: <1% failure (user‑independent).
  • Convenience: No daily/weekly action needed.
  • Rapid Return to Fertility: Immediate after removal (except DMPA: 9–10 months).
  • Non‑Contraceptive Benefits: Hormonal IUD reduces bleeding/pain; implant reduces dysmenorrhea; copper IUD works as emergency contraception.
  • Cost‑Effective: Lowest cost per year over duration.
  • Safe for Most: Including adolescents, postpartum, breastfeeding, and post‑abortion.

Common Concerns & Evidence‑Based Responses

Concern Evidence‑Based Response
Pain with insertion Pre‑procedure NSAID; cervical block; expect brief cramping.
Expulsion (IUD) 2–10% (higher postpartum, <25); check strings; replace if expelled.
Perforation (IUD) ~1/1000; higher postpartum/breastfeeding; usually asymptomatic.
Irregular Bleeding Common 3–6 months; hormonal IUD → lighter/amenorrhea; implant → unpredictable.
Weight Gain DMPA: average +5 lbs/yr; IUD/Implant: minimal/no causal link.
Mood Changes Mixed evidence; DMPA most associated; consider non‑hormonal if history.
Infertility Myth No delay in fertility return after removal (except DMPA).

Contraindications (CDC MEC Categories 3–4)

  • Hormonal IUD/Implant: Current breast cancer (Cat 4); liver tumor (Cat 3/4); unexplained vaginal bleeding (evaluate first).
  • Copper IUD: Copper allergy, Wilson’s disease, active PID, uterine anomaly distorting cavity.
  • DMPA: Current breast cancer, active VTE, severe cirrhosis, multiple fracture risks.

Emergency Contraception Note

Copper IUD is the most effective EC (99.9% if placed ≤5 days post‑intercourse). Hormonal IUD (LNG 52 mg) also effective. Ulipristal acetate (Ella) 85% effective ≤5 days. Levonorgestrel pills (Plan B) 75–89% effective ≤3 days.

Action: Discuss LARC at any reproductive health visit. Same‑day insertion increasingly available. Removal anytime = rapid fertility return.

Pregnancy & Health - Related Articles